<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gastro-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Gastroenterology, Hepatology, Coloproctology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1382-4376</issn><issn pub-type="epub">2658-6673</issn><publisher><publisher-name>«Gastro» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22416/1382-4376-2025-35-1-64-73</article-id><article-id custom-type="elpub" pub-id-type="custom">gastro-j-1557</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Клиническое наблюдение: пациент со слабостью, кожными высыпаниями, повышением активности трансаминаз и уровня билирубина</article-title><trans-title-group xml:lang="en"><trans-title>Clinical Case: A Patient with Weakness, Skin Rashes, Increased Transaminase Activity and Bilirubin Levels</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5524-1616</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Давыдов Денис Андреевич — врач-ревматолог </p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6–8. </p></bio><bio xml:lang="en"><p>Davydov A. Denis — Rheumatologist </p><p>197022, Saint Petersburg, L’va Tolstogo str., 6–8.</p></bio><email xlink:type="simple">davydov.rheum@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-7943-6817</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифорова</surname><given-names>Э. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никифорова Элина Александровна — студентка лечебного факультета </p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6–8. </p></bio><bio xml:lang="en"><p>Elina A. Nikiforova — Student of General Medicine Faculty </p><p>197022, Saint Petersburg, L’va Tolstogo str., 6–8.</p></bio><email xlink:type="simple">nikiflina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-4720-3461</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ким</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ким Арина Анатольевна — клинический ординатор по специальности «Ревматология» </p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6–8. </p></bio><bio xml:lang="en"><p>Arina A. Kim — Clinical Resident in the specialty “Rheumatology” </p><p>197022, Saint Petersburg, L’va Tolstogo str., 6–8.</p></bio><email xlink:type="simple">arina.kim7777@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7972-1286</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карев</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Karev</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карев Вадим Евгеньевич — доктор медицинских наук, руководитель отдела патоморфологии; профессор Научно-клинического и образовательного центра гастроэнтерологии и гепатологии медицинского института </p><p>197022, г. Санкт-Петербург, ул. Профессора Попова, 9. </p></bio><bio xml:lang="en"><p>Vadim E. Karev — Dr. Sci. (Med.), Head of the Department of Pathology; Professor of Scientific and Educational Center of Gastroenterology and Hepatology of the Medical Institute </p><p>197022, Saint Petersburg, Professorа Popovа str., 9.</p></bio><email xlink:type="simple">vadimkarev@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0972-3363</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Якубовский</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakubovsky</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Якубовский Андрей Валентинович — кандидат медицинских наук, доцент кафедры дерматовенерологии с клиникой </p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6–8. </p></bio><bio xml:lang="en"><p>Andrey V. Yakubovsky — Cand. Sci. (Med.), Associate Professor of the Department of Dermatovenerology with  a Clinic </p><p>197022, Saint Petersburg, L’va Tolstogo str., 6–8.</p></bio><email xlink:type="simple">ayakubovsky@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8821-6142</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Райхельсон</surname><given-names>К. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Raikhelson</surname><given-names>K. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Райхельсон Карина Леонидовна — доктор медицинских наук, доцент, профессор кафедры общей врачебной практики; профессор Научно-клинического и образовательного центра гастроэнтерологии и гепатологии Медицинского института </p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6–8. </p></bio><bio xml:lang="en"><p>Karina L. Raikhelson — Dr. Sci. (Med.), Docent, Professor of the Department of General Medical Practice; Professor of the Scientific and Educational Center of Gastroenterology and Hepatology of the Medical Institute </p><p>197022, Saint Petersburg, L’va Tolstogo str., 6–8.</p></bio><email xlink:type="simple">kraikhelson@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician I.P. Pavlov First St. Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Федеральный научно-клинический центр инфекционных болезней Федерального медико-биологического агентства»;&#13;
ФГБОУ ВО «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research and Clinical Center for Infectious Diseases under the Federal Medical Biological Agency;&#13;
Saint Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова» Министерства здравоохранения Российской Федерации;&#13;
ФГБОУ ВО «Санкт-Петербургский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academician I.P. Pavlov First St. Petersburg State Medical University;&#13;
Saint Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>01</month><year>2025</year></pub-date><volume>35</volume><issue>1</issue><fpage>64</fpage><lpage>73</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Давыдов Д.А., Никифорова Э.А., Ким А.А., Карев В.Е., Якубовский А.В., Райхельсон К.Л., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Давыдов Д.А., Никифорова Э.А., Ким А.А., Карев В.Е., Якубовский А.В., Райхельсон К.Л.</copyright-holder><copyright-holder xml:lang="en">Davydov D.A., Nikiforova E.A., Kim A.A., Karev V.E., Yakubovsky A.V., Raikhelson K.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gastro-j.ru/jour/article/view/1557">https://www.gastro-j.ru/jour/article/view/1557</self-uri><abstract><p>Цель: повысить осведомленность врачей о дифференциальной диагностике аутоиммунного гепатита и диффузных заболеваний соединительной ткани. Основные положения. Описано клиническое наблюдение пациента с дерматомиозитом, протекавшим на фоне атопического дерматита и синдрома Жильбера, имитировавшим аутоиммунное заболевание печени и осложнившимся развитием лекарственного поражения печени. Рассмотрены вопросы диагностики и дифференциальной диагностики аутоиммунного гепатита. Обсуждена строгая обязательность морфологического исследования печени для постановки диагноза. Проанализированы вторичные поражения печени при диффузных заболеваниях соединительной ткани и лекарственное поражение печени, ассоциированное с азатиоприном.Заключение. Дифференциальный диагноз при повышении сывороточных трансаминаз должен включать в себя не только заболевания печени, но и патологию мышечной ткани. При постановке диагноза АИГ гистологическое исследование играет ключевую роль, и верификация диагноза невозможна без морфологических данных.</p></abstract><trans-abstract xml:lang="en"><p>Aim: to increase physicians’ awareness of differential diagnosis of autoimmune hepatitis and diffuse connective tissue disease using a clinical case as an example. Key points. The article describes a clinical observation of a 34-year-old patient with dermatomyositis occurring against the background of atopic dermatitis and Gilbert’s syndrome, imitating autoimmune liver disease and complicated by the development of drug-induced liver injury. The complexity of diagnosis was determined by the development of skin lesions against the background of changes already present as a result of the atopic dermatitis, laboratory data (increased transaminase activity, bilirubin levels, and detection of antinuclear and anti-smooth muscle autoantibodies indicating a suspected liver disease), and the disappearance of a number of typical signs of the disease as a result of previously prescribed immunosuppressive therapy. The diagnosis was established through a thorough retrospective analysis of the clinical manifestations and anamnesis of the disease (a change in the nature of skin rashes and the predominance of increased activity of aspartate transaminase were noteworthy); the key moment for making the diagnosis was the detection of increased activity of creatine kinase and myositis-specific antibodies Jo-1. Morphological examination of liver tissue did not find signs of autoimmune hepatitis and liver fibrosis, but revealed centrilobular intracellular cholestasis and lymphohistiocytic infiltration, proliferative changes in the biliary epithelium, probably caused by drug-induced liver injury due to azathioprine intake. The issues of diagnostics and differential diagnosis of autoimmune hepatitis are considered, the strict necessity of morphological examination of the liver for diagnosis is discussed. Secondary liver injury in diffuse connective tissue disease and azathioprineinduced liver injury are analyzed. Conclusion. Differential diagnosis of elevated serum transaminases should include not only liver disease, but also muscle tissue injury. When diagnosing autoimmune hepatitis, histological examination plays a key role, and verification of the diagnosis is impossible without morphological data.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>аутоиммунные заболевания печени</kwd><kwd>аутоиммунный гепатит</kwd><kwd>дерматомиозит</kwd><kwd>полимиозит</kwd><kwd>поражение печени</kwd><kwd>лекарственное поражение печени</kwd><kwd>азатиоприн</kwd></kwd-group><kwd-group xml:lang="en"><kwd>autoimmune liver disease</kwd><kwd>autoimmune hepatitis</kwd><kwd>dermatomyositis</kwd><kwd>polymyositis</kwd><kwd>liver damage</kwd><kwd>druginduced liver injury</kwd><kwd>azathioprine</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Атопический дерматит: клинические рекомендации. 2024. URL: https://www.medznat.ru/uploads/file/post/ru/9359/17297545049359.pdf</mixed-citation><mixed-citation xml:lang="en">Atopic dermatitis: Clinical guidelines. 2024. (In Russ.). URL: https://www.medznat.ru/uploads/file/post/ru/9359/17297545049359.pdf</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23–31. DOI: 10.1159/000247298</mixed-citation><mixed-citation xml:lang="en">Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23–31. DOI: 10.1159/000247298</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.J., Zeidi M., Bonciani D., Pena S.M., Tiao J., Sahu S., et al. Itch in dermatomyositis: The role of increased skin interleukin-31. Br J Dermatol. 2018;179(3):669–78. DOI: 10.1111/bjd.16498</mixed-citation><mixed-citation xml:lang="en">Kim H.J., Zeidi M., Bonciani D., Pena S.M., Tiao J., Sahu S., et al. Itch in dermatomyositis: The role of increased skin interleukin-31. Br J Dermatol. 2018;179(3):669–78. DOI: 10.1111/bjd.16498</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Xu A., Fu Q. Heliotrope rash. BMJ. 2023;382:e075978. DOI: 10.1136/bmj-2023-075978</mixed-citation><mixed-citation xml:lang="en">Xu A., Fu Q. Heliotrope rash. BMJ. 2023;382:e075978. DOI: 10.1136/bmj-2023-075978</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Трисветова Е.Л. Диагностика интерстициальных заболеваний легких при системных заболеваниях соединительной ткани. Медицинские новости. 2021;7(322):22–8.</mixed-citation><mixed-citation xml:lang="en">Trisvetova E.L. Diagnosis of interstitial lung diseases in systemic connective tissue diseases. Meditsinskie novosti. 2021;7(322):22–8. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Isenberg D.A., Allen E., Farewell V., Ehrenstein M.R., Hanna M.G., Lundberg I.E., et al.; International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford). 2004;43(1):49–54. DOI: 10.1093/rheumatology/keg427</mixed-citation><mixed-citation xml:lang="en">Isenberg D.A., Allen E., Farewell V., Ehrenstein M.R., Hanna M.G., Lundberg I.E., et al.; International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford). 2004;43(1):49–54. DOI: 10.1093/rheumatology/keg427</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lundberg I.E., Tjärnlund A., Bottai M., Werth V.P., Pilkington C., de Visser M., et al.; International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69(12):2271–82. DOI: 10.1002/art.40320</mixed-citation><mixed-citation xml:lang="en">Lundberg I.E., Tjärnlund A., Bottai M., Werth V.P., Pilkington C., de Visser M., et al.; International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69(12):2271–82. DOI: 10.1002/art.40320</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–7. DOI: 10.1056/NEJM197502202920807</mixed-citation><mixed-citation xml:lang="en">Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–7. DOI: 10.1056/NEJM197502202920807</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lohse A.W., Sebode M., Bhathal P.S., Clouston A.D., Dienes H.P., Jain D., et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int. 2022;42(5):1058–69. DOI: 10.1111/liv.15217</mixed-citation><mixed-citation xml:lang="en">Lohse A.W., Sebode M., Bhathal P.S., Clouston A.D., Dienes H.P., Jain D., et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int. 2022;42(5):1058–69. DOI: 10.1111/liv.15217</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Vergani G., Vergani D., et al.; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–213. DOI: 10.1002/hep.23584</mixed-citation><mixed-citation xml:lang="en">Manns M.P., Czaja A.J., Gorham J.D., Krawitt E.L., Mieli-Vergani G., Vergani D., et al.; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–213. DOI: 10.1002/hep.23584</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Woodward J., Neuberger J. Autoimmune overlap syndromes. Hepatology. 2001;33(4):994–1002. DOI: 10.1053/jhep.2001.23316</mixed-citation><mixed-citation xml:lang="en">Woodward J., Neuberger J. Autoimmune overlap syndromes. Hepatology. 2001;33(4):994–1002. DOI: 10.1053/jhep.2001.23316</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hounoki H., Shinoda K., Ogawa R., Taki H., Tsuneyama K., Tobe K. Simultaneously developed polymyositis and autoimmune hepatitis. BMJ Case Rep. 2011;2011:bcr0920114763 DOI: 10.1136/bcr.09.2011.4763</mixed-citation><mixed-citation xml:lang="en">Hounoki H., Shinoda K., Ogawa R., Taki H., Tsuneyama K., Tobe K. Simultaneously developed polymyositis and autoimmune hepatitis. BMJ Case Rep. 2011;2011:bcr0920114763 DOI: 10.1136/bcr.09.2011.4763</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hirschfield G.M., Gill P., Neuberger J. The liver in systemic disease: A clinician's guide to abnormal liver tests. Hoboken, NJ: John Wiley &amp; Sons, Inc.; 2023. DOI: 10.1002/9781119802181</mixed-citation><mixed-citation xml:lang="en">Hirschfield G.M., Gill P., Neuberger J. The liver in systemic disease: A clinician's guide to abnormal liver tests. Hoboken, NJ: John Wiley &amp; Sons, Inc.; 2023. DOI: 10.1002/9781119802181</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">De Santis M., Crotti C., Selmi C. Liver abnormalities in connective tissue diseases. Best Pract Res Clin Gastroenterol. 2013;27(4):543–51. DOI: 10.1016/j.bpg.2013.06.016</mixed-citation><mixed-citation xml:lang="en">De Santis M., Crotti C., Selmi C. Liver abnormalities in connective tissue diseases. Best Pract Res Clin Gastroenterol. 2013;27(4):543–51. DOI: 10.1016/j.bpg.2013.06.016</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vergani D., Alvarez F., Bianchi F.B., Cançado E.L., Mackay I.R., Manns M.P., et al.; International Autoimmune Hepatitis Group. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41(4):677–83. DOI: 10.1016/j.jhep.2004.08.002</mixed-citation><mixed-citation xml:lang="en">Vergani D., Alvarez F., Bianchi F.B., Cançado E.L., Mackay I.R., Manns M.P., et al.; International Autoimmune Hepatitis Group. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41(4):677–83. DOI: 10.1016/j.jhep.2004.08.002</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ткаченко О.Ю., Лапин С.В., Мазинг А.В., Тотолян Арег А. Русскоязычная адаптация международной номенклатуры типов свечения ядра и цитоплазмы клетки (ICAP) для стандартизации выявления антинуклеарного фактора. Медицинская иммунология. 2020;6:1195–214. DOI: 10.15789/1563-0625-RVO-2067</mixed-citation><mixed-citation xml:lang="en">Tkachenko O.Yu., Lapin S.V., Mazing A.V., Totolian Areg A. Russian-language version of the International Nomenclature of International Consensus on Antinuclear Antibody (ANA) Patterns (ICAP). Medical Immunology (Russia). 2020;6:1195–214. (In Russ.). DOI: 10.15789/1563-0625-RVO-2067</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Damoiseaux J., von Mühlen C.A., Garcia-De La Torre I., Carballo O.G., de Melo Cruvinel W., Francescantonio P.L., et al. International consensus on ANA patterns (ICAP): The bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights. 2016;7(1):1. DOI: 10.1007/s13317-016-0075-0</mixed-citation><mixed-citation xml:lang="en">Damoiseaux J., von Mühlen C.A., Garcia-De La Torre I., Carballo O.G., de Melo Cruvinel W., Francescantonio P.L., et al. International consensus on ANA patterns (ICAP): The bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights. 2016;7(1):1. DOI: 10.1007/s13317-016-0075-0</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Galaski J., Weiler-Normann C., Schakat M., Zachou K., Muratori P., Lampalzer S., et al. Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing. J Hepatol. 2021;74(2):312–20. DOI: 10.1016/j.jhep.2020.07.032</mixed-citation><mixed-citation xml:lang="en">Galaski J., Weiler-Normann C., Schakat M., Zachou K., Muratori P., Lampalzer S., et al. Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing. J Hepatol. 2021;74(2):312–20. DOI: 10.1016/j.jhep.2020.07.032</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015;63(4):971–1004. DOI: 10.1016/j.jhep.2015.06.030</mixed-citation><mixed-citation xml:lang="en">European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015;63(4):971–1004. DOI: 10.1016/j.jhep.2015.06.030</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Винницкая Е.В., Сандлер Ю.Г., Абдурахманов Д.Т., Бакулин И.Г., Белоусова Е.А., Буеверов А.О. и др. Ключевые положения Российского консенсуса по диагностике и лечению аутоиммунного гепатита. Фарматека. 2017;5(17):47–55.</mixed-citation><mixed-citation xml:lang="en">Vinnitskaya E.V., Sandler Yu.G., Abdurakhmanov D.T., Bakulin I.G., Belousova E.A., Buyeverov A.O., et al. Main provisions of the Russian consensus on diagnosis and treatment of autoimmune hepatitis. Farmateka. 2017;5(17):47–55. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Винницкая Е.В., Сандлер Ю.Г., Бакулин И.Г., Парфенов А.И., Ильченко А.Ю., Никитин И.Г. и др. Актуальные вопросы диагностики и лечения аутоиммунного гепатита (по материалам Российского консенсуса 2017 г.). Терапевтический архив. 2018;90(2):12–8. DOI: 10.26442/terarkh201890212-18</mixed-citation><mixed-citation xml:lang="en">Vinnitskaya E.V., Sandler Yu.G., Bakulin I.G., Parfenov A.I., Ilchenko L.Yu, Nikitin I.G., et al. Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017). Terapevticheskii arkhiv. 2018;90(2):12–8. (In Russ.). DOI: 10.26442/terarkh201890212-18</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mack C.L., Adams D., Assis D.N., Kerkar N., Manns M.P., Mayo M.J., et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671–722. DOI: 10.1002/hep.31065</mixed-citation><mixed-citation xml:lang="en">Mack C.L., Adams D., Assis D.N., Kerkar N., Manns M.P., Mayo M.J., et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671–722. DOI: 10.1002/hep.31065</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–76. DOI: 10.1002/hep.22322</mixed-citation><mixed-citation xml:lang="en">Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–76. DOI: 10.1002/hep.22322</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi A., Takeda I., Kanno T., Nakahara T., Odajima H., Kasukawa R. CD8-positive T cell-induced liver damage was found in a patient with polymyositis. Intern Med. 2006;45(18):1059–63. DOI: 10.2169/internalmedicine.45.1710</mixed-citation><mixed-citation xml:lang="en">Takahashi A., Takeda I., Kanno T., Nakahara T., Odajima H., Kasukawa R. CD8-positive T cell-induced liver damage was found in a patient with polymyositis. Intern Med. 2006;45(18):1059–63. DOI: 10.2169/internalmedicine.45.1710</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi A., Abe K., Yokokawa J., Iwadate H., Kobayashi H., Watanabe H., et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res. 2010;40(11):1092–7. DOI: 10.1111/j.1872-034X.2010.00707.x</mixed-citation><mixed-citation xml:lang="en">Takahashi A., Abe K., Yokokawa J., Iwadate H., Kobayashi H., Watanabe H., et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res. 2010;40(11):1092–7. DOI: 10.1111/j.1872-034X.2010.00707.x</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wada T., Abe G., Kudou T., Ogawa E., Nagai T., Tanaka S., et al. Liver damage in patients with polymyositis and dermatomyositis. Kitasato Med J. 2016;46:40–6.</mixed-citation><mixed-citation xml:lang="en">Wada T., Abe G., Kudou T., Ogawa E., Nagai T., Tanaka S., et al. Liver damage in patients with polymyositis and dermatomyositis. Kitasato Med J. 2016;46:40–6.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Noda S., Asano Y., Tamaki Z., Takekoshi T., Sugaya M., Sato S. A case of dermatomyositis with “liver disease associated with rheumatoid diseases” positive for anti-liver-kidney microsome-1 antibody. Clin Rheumatol. 2010;29(8):941–3. DOI: 10.1007/s10067-010-1397-3</mixed-citation><mixed-citation xml:lang="en">Noda S., Asano Y., Tamaki Z., Takekoshi T., Sugaya M., Sato S. A case of dermatomyositis with “liver disease associated with rheumatoid diseases” positive for anti-liver-kidney microsome-1 antibody. Clin Rheumatol. 2010;29(8):941–3. DOI: 10.1007/s10067-010-1397-3</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Azathioprine. Last Update: August 21, 2017. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. URL https://www.ncbi.nlm.nih.gov/books/NBK548332/</mixed-citation><mixed-citation xml:lang="en">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Azathioprine. Last Update: August 21, 2017. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. URL https://www.ncbi.nlm.nih.gov/books/NBK548332/</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Björnsson E.S., Gu J., Kleiner D.E., Chalasani N., Hayashi P.H., Hoofnagle J.H.; DILIN Investigators. Azathioprine and 6-mercaptopurine-induced liver injury: Clinical features and outcomes. J Clin Gastroenterol. 2017;51(1):63–9. DOI: 10.1097/MCG.0000000000000568</mixed-citation><mixed-citation xml:lang="en">Björnsson E.S., Gu J., Kleiner D.E., Chalasani N., Hayashi P.H., Hoofnagle J.H.; DILIN Investigators. Azathioprine and 6-mercaptopurine-induced liver injury: Clinical features and outcomes. J Clin Gastroenterol. 2017;51(1):63–9. DOI: 10.1097/MCG.0000000000000568</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kleiner D.E., Chalasani N.P., Lee W.M., Fontana R.J., Bonkovsky H.L., Watkins P.B., et al.; Drug-Induced Liver Injury Network (DILIN). Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Hepatology. 2014;59(2):661–70. DOI: 10.1002/hep.26709</mixed-citation><mixed-citation xml:lang="en">Kleiner D.E., Chalasani N.P., Lee W.M., Fontana R.J., Bonkovsky H.L., Watkins P.B., et al.; Drug-Induced Liver Injury Network (DILIN). Hepatic histological findings in suspected drug-induced liver injury: Systematic evaluation and clinical associations. Hepatology. 2014;59(2):661–70. DOI: 10.1002/hep.26709</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Rinella M.E., Lazarus J.V., Ratziu V., Francque S.M., Sanyal A.J.; Kanwal F., et al.; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–86. DOI: 10.1097/HEP.0000000000000520</mixed-citation><mixed-citation xml:lang="en">Rinella M.E., Lazarus J.V., Ratziu V., Francque S.M., Sanyal A.J.; Kanwal F., et al.; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–86. DOI: 10.1097/HEP.0000000000000520</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Liebe R., Esposito I., Bock H.H., Vom Dahl S., Stindt J., Baumann U., et al. Diagnosis and management of secondary causes of steatohepatitis. J Hepatol. 2021;74(6):1455–71. DOI: 10.1016/j.jhep.2021.01.045</mixed-citation><mixed-citation xml:lang="en">Liebe R., Esposito I., Bock H.H., Vom Dahl S., Stindt J., Baumann U., et al. Diagnosis and management of secondary causes of steatohepatitis. J Hepatol. 2021;74(6):1455–71. DOI: 10.1016/j.jhep.2021.01.045</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Hayashi P.H., Lucena M.I., Fontana R.J. RECAM: A new and improved, computerized causality assessment tool for DILI diagnosis. Am J Gastroenterol. 2022;117(9): 1387–9. DOI: 10.14309/ajg.0000000000001836</mixed-citation><mixed-citation xml:lang="en">Hayashi P.H., Lucena M.I., Fontana R.J. RECAM: A new and improved, computerized causality assessment tool for DILI diagnosis. Am J Gastroenterol. 2022;117(9): 1387–9. DOI: 10.14309/ajg.0000000000001836</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Danan G., Benichou C. Causality assessment of adverse reactions to drugs — I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323–30. DOI: 10.1016/0895-4356(93)90101-6</mixed-citation><mixed-citation xml:lang="en">Danan G., Benichou C. Causality assessment of adverse reactions to drugs — I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323–30. DOI: 10.1016/0895-4356(93)90101-6</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
